ID: PMRREP3923
Format: PPT*, PDF, EXCEL
Last Updated: 8 July 2025
Industry: Chemicals and Materials
Number of Pages: 192
The global household insecticides market size is likely to be valued at USD 18.3 Bn in 2025 and is expected to reach USD 29.6 Bn by 2032, growing at a CAGR of approximately 7.1%, during the forecast period 2025 to 2032.
In India, Mortein launched the ‘Suraksha Ka Teeka’ initiative and the dual-action two-in-one spray campaign in 2024, addressing mosquitoes and cockroach infestations, particularly during monsoon seasons. These launches reflect a shift toward culturally integrated, research-backed solutions that enhance community-level protection.
Flies and mosquitoes continue to pose significant health threats in tropical regions. WHO estimates that food-borne illnesses commonly linked to fly contamination cause 600 million cases and 420,000 deaths each year, with Africa and Southeast Asia accounting for the largest share. The 2024 WHO manual on indoor residual spraying supports prevention across regions prone to vector-borne diseases such as malaria and dengue.
Oxitec’s pilot deployment of Friendly™ mosquito devices in the Marshall Islands targets Aedes aegypti populations, offering biologically driven intervention in densely populated areas with frequent dengue outbreaks.
North America and parts of Europe are experiencing a rise in rodent-borne and bedbug-related health risks. In the U.S., CDC data reports 2,000–4,000 annual cases of rat-bite fever, and studies from South India show over 55% prevalence of Orientia tsutsugamushi in rats. Bedbug activity continues to surge in homes, hotels, and dorms, with more than 90% of U.S. pest professionals reporting service calls in 2023.
Urban mobility, rising temperatures, and seasonal travel have intensified infestations, leading to increased demand for products targeting ants, bedbugs, moths, rodents, and flies across both developed and developing regions.
Key Industry Highlights:
|
Global Market Attribute |
Details |
|
Market Size (2024A) |
US$ 17.2 Bn |
|
Estimated Market Size (2025E) |
US$ 18.3 Bn |
|
Projected Market Value (2032F) |
US$ 29.6 Bn |
|
Value CAGR (2025 to 2032) |
7.1% |
|
Historical Market Growth (CAGR 2019 to 2024) |
6.4% |
Vector-borne diseases continue to surge across regions, pushing families to adopt more aggressive insect control routines at home. According to the World Health Organization, more than 700,000 people annually succumb to these diseases which account for over 17% of all infectious illnesses globally. Dengue alone threatens 3.9 billion people in 132 countries, causing around 96 million symptomatic cases and 40,000 deaths each year. These rising infection rates fuel daily use of indoor mosquito repellents, vaporizing devices, and sprays to block transmission inside living spaces.
With added pressure from diseases such as Zika, chikungunya, and yellow fever, residents in risk-prone zones intensify their reliance on personal defense tools. Families increasingly prefer fast-acting and longer-lasting products, including coils, creams, and insect-killing aerosols.
This everyday use pattern drives steady volume growth for companies offering reliable, safe, and accessible solutions for home use, making disease prevalence a major catalyst behind category expansion.
Vector resistance to commonly used chemical formulations is growing, making it harder for products to deliver consistent results. According to WHO and CSIRO data, species like Aedes aegypti and Culex pipiens are adapting to widely used actives, reducing the long-term effectiveness of traditional repellents and sprays. In Europe, invasive mosquitoes spread across 13 countries in 2023, with rising West Nile virus cases pointing to the limits of older vector control approaches. This resistance trend threatens to weaken consumer trust in familiar solutions.
Australia and the U.S. are also seeing resistance issues. CSIRO and Oxitec's launch of Friendly™ genetic mosquito technology in January 2025 shows a pivot away from chemical-heavy solutions.
In the U.S., the CDC’s decades-long struggle with recurring malaria and dengue cases reinforces the need for smarter formulations. Without innovation, product cycles shorten, costs increase, and companies lose ground in high-risk areas where performance matters most.
As malaria continues to kill more than 600,000 people each year mostly children under five communities are proactively integrating preventive steps into daily routines.
In tropical and subtropical zones, households now use mosquito mats, plug-in vaporizers, and repellent lotions as part of their lifestyle. These home-use pest control tools are gaining traction, especially in semi-urban belts where awareness of disease prevention is improving.
People are also responding to broader risks from tick-borne encephalitis and Japanese encephalitis, shifting preference toward safer and environmentally friendly options. Natural repellents, low-toxicity aerosols, and herbal roll-ons are becoming preferred picks for families looking to protect children and the elderly.
This behavior change, supported by government and health body campaigns, is unlocking fresh potential in emerging markets for players focused on comfort, health safety, and innovation.
Stricter regulatory measures, such as the U.S. EPA’s Insecticide Strategy, are reshaping how the industry approaches pest control products used in homes. With over 900 endangered and threatened species at the center of new environmental protections, manufacturers now reengineer their formulations to reduce ecological risks. Updated guidelines on spray drift, buffer zones, and species protection create a landscape where sustainability is no longer optional. The focus shifts from reactive compliance to proactive integration of eco-principles right at the R&D stage.
This regulatory clarity offers manufacturers the confidence to design targeted, low-toxicity solutions without compromising performance. Consumer demand reinforces this shift people now seek effective products that are also safe for indoor use, pets, and the planet. Backed by industry support, such as from the American Soybean Association and National Cotton Council, this trend sets the stage for a new generation of precise, environmentally responsible pest management tools tailored for household use.
The liquid category segment holds the market share of 37.8%, driven by increasing consumer demand for fast-acting, long-lasting mosquito protection. The launch of Mortein Smart+ on March 18, 2023, marked a significant shift in product innovation. This vaporiser features India’s most powerful mosquito protection formula, offering continued efficacy for two hours after switching off. The formulation, tested at the Mortein Advanced Research Lab, aligns with rising health concerns tied to vector-borne diseases and is designed for higher efficacy even in larger spaces.
On July 13, 2024, Godrej Consumer Products Ltd (GCPL) introduced Renofluthrin, a patented repellent molecule developed with Shogun. Integrated into GCPL’s liquid vaporiser portfolio, this innovation claims to double the effectiveness of traditional solutions. GCPL secured exclusive usage rights for six to eight years, reinforcing its competitive edge in mosquito control solutions. These developments reflect a growing shift toward proprietary technologies and performance-driven formulations in the vaporiser segment.
The mosquito control segment commands 44.3% of the market in 2025. In India, rising vector-borne diseases during the monsoon are pushing innovation. Godrej HIT’s new Thunderbolt spray, launched in April 2024, uses Metofluthrin to offer four times faster knockdown with less aerosol. It follows earlier launches like incense sticks and Renofluthrin-based formulas. Mortein’s 2-in-1 spray, released in September 2024, targets mosquitoes and cockroaches and gained attention through its ‘Bacche Bacche Ko Pataa Hai’ campaign. Strategic pricing and visible efficacy help drive adoption.
Europe faces a changing mosquito landscape. According to the ECDC, invasive species like Aedes aegypti and Aedes albopictus are spreading northward due to climate change. In 2023, 130 local dengue cases were reported in the EU/EEA, nearly doubling from 2022. Imported cases surged past 4,900 the highest since EU surveillance began. Regions infected by West Nile virus also hit record levels, with 713 human cases and 67 deaths in 2023. The native Culex pipiens continues to carry the virus across Europe.
In the U.S., the CDC highlights long-standing exposure to mosquito-related illnesses. Over the past 50 years, the country saw more than 150 local mosquito-borne cases and over 60 outbreaks. Malaria continues to affect over 2,000 people annually, mostly returning travelers.
On a global front, Oxitec and CSIRO launched Oxitec Australia in December 2024 to fight Aedes mosquito populations with Friendly™ genetic technology. Their biological method reduces disease transmission risk without chemicals. This effort reflects growing reliance on bio-solutions for mosquito management across continents.
South Asia and Oceania hold a 25.6% share in the household insecticide market, led by severe mosquito-borne disease outbreaks and the rollout of smart pest control solutions. India reports over 40 million annual cases of illnesses such as malaria, dengue, and chikungunya, with the WHO attributing 17% of global infectious diseases to vector-borne sources.
In September 2024, Godrej Consumer Products Ltd introduced HIT Spray Matic, India's first government-registered automatic mosquito spray device, addressing urban demand for tech-enabled protection. The company’s recognition by the Dow Jones Sustainability Index in December 2024 reinforces its commitment to safer, sustainable consumer goods.
In Oceania, mosquito risks are rising as climate change expands breeding zones across Australia. CSIRO and Oxitec Ltd launched Oxitec Australia in January 2025 to deploy Friendly™ mosquito technology targeting Aedes aegypti, which transmits dengue and Zika.
According to NIH data, Australia sees over 5,400 Ross River virus infections yearly, with Queensland accounting for nearly half. Public health bodies like Queensland Health and the Australian Government emphasize source reduction and personal protection to control outbreaks. This regional urgency continues to reshape consumer preferences and drive the adoption of modern pest control products.
East Asia holds a 19.3% share in the household insecticide market, driven by rising mosquito-borne diseases and national surveillance efforts.
In China, the National Health Commission reported 19,627 dengue fever cases in 2023, with provinces like Zhejiang contributing 361 cases. Although December 2024 showed a decline to 442 cases from 5,201 in November, the overall burden remains high, with cumulative cases crossing 106,000 and 13 deaths over the years. WHO highlights dengue and Japanese encephalitis as key threats, with JEV alone causing an estimated 100,000 clinical cases annually across Asia, particularly affecting children under 15. The disease has no cure but can be prevented through vaccination programs, which the WHO recommends for endemic areas.
In South Korea, the Korea Disease Control and Prevention Agency (KDCA) runs annual surveillance across 169 national sites and 13 port/quarantine zones. Its 2025 program includes monitoring vectors responsible for diseases such as Japanese encephalitis, dengue, malaria, and Zika. In 2024, Korea recorded 21 local JE cases and 659 malaria cases. These figures underscore persistent regional exposure to mosquito-borne threats.
Joint public-private monitoring initiatives coordinated by KDCA, the Ministry of Defense, and Climate Change Hub Center aim to manage this risk. With growing awareness and product demand, companies like GCPL continue to report strong growth in their insect control segments globally, reinforcing East Asia’s significance in the expanding market.
The household insecticide market is moderately consolidated, led by a core group of companies focused on continuous innovation and regional adaptation. Godrej Consumer Products Ltd (GCPL) shows strong momentum through repeated product launches and technological advancements, especially with new formulations and smart delivery devices. The company’s exclusive collaborations and sustainability achievements position it as a forward-looking leader, integrating health protection with eco-conscious development. Reckitt Benckiser Group, through Mortein, strengthens its market presence by combining product innovation with culturally resonant marketing campaigns and targeted seasonal outreach, reinforcing consumer trust and recall.
Other key players such as S. C. Johnson and Son Inc., Tiger Brands Ltd., Kombat, and Pelgar International Limited contribute to market dynamism through diversified offerings across global and emerging markets.
Players like Oxitec Ltd and CSIRO are reshaping the biological vector control space via strategic joint ventures and public-private collaborations, addressing long-term challenges like pesticide resistance.
Technological advancements from NEOGEN Corporation, though focused on agriculture, signal future crossover potential into home-use formulations. Overall, companies are focusing on collaborations, product launches, awareness initiatives, and sustainability goals, shaping a competitive but innovation-intensive environment.
The global market is projected to be valued at US$ 18.3 Bn in 2025.
The liquid product type is expected to hold a 37.8% share in the household insecticides market, driven by increasing demand for fast-acting, long-lasting mosquito protection and innovations like vaporisers with advanced repellent formulations.
The market is poised to witness a CAGR of 7.1% from 2025 to 2032.
Rising vector-borne diseases and consumer preference for fast-acting, long-lasting protection are key drivers of market growth.
Increasing preventive health awareness and growing demand for eco-friendly, low-toxicity solutions present strong market opportunities.
Key players include Godrej Consumer Products Ltd, Reckitt Benckiser Group PLC, S. C. Johnson and Son Inc., Tiger Brands Ltd., Kombat, and Pelgar International Limited.
|
Report Attribute |
Details |
|
Forecast Period |
2025 to 2032 |
|
Historical Data Available for |
2019 to 2024 |
|
Market Analysis |
USD Million for Value |
|
Key Regions Covered |
|
|
Key Companies Covered |
|
|
Report Coverage
|
|
|
Customization and Pricing |
Available on Report |
By Product Type
By Nature
By Sales Channel
By Application
By Region
For more information on this report and its delivery timelines please get in touch with our sales team.
